Rosen Law Firm Targets The Ensign Group Over Alleged Misleading Metrics

The Hunterbrook report, which surfaced after a five-month investigation, claims that the company’s business model prioritizes executive payouts over patient welfare. These allegations suggest that taxpayer funds are being diverted to affiliates while facilities remain understaffed, resulting in claims of patient neglect and fatalities. Rosen Law Firm is now seeking to organize a class action on behalf of investors who may have suffered losses due to the company's potentially misleading business disclosures.

Investors who held Ensign Group securities during the period in question are encouraged to contact attorney Phillip Kim to participate in the prospective litigation. The firm operates on a contingency fee basis, meaning shareholders are not required to pay out-of-pocket costs to join the action. Rosen Law Firm maintains a significant history in securities litigation, including high-profile settlements and rankings from ISS Securities Class Action Services, as it attempts to recover damages for those impacted by the stock's recent volatility.